Remove 2030 Remove Drug Research Remove Trials
article thumbnail

Distinguishing the Roles of Preclinical vs. Clinical CROs in Clinical Research

Vial

Distinguishing the Roles of Preclinical vs. Clinical CROs in Clinical Research Randomized clinical trials are the gold-standard of evidence-based medicine, representing the culmination of the long, arduous drug development pipeline. billion by 2030 at a compound annual growth rate (CAGR) of 7.5% between 2024 and 2030.

article thumbnail

Possible adulticidal drugs for Onchocerca volvulus

Drug Target Review

If these genomes that codes for the proposed enzymes and biomolecules are critical to the worms as projected by Cotton et al (2016), then thus it creates countless opportunity for adulticidal drugs to be developed. She spent one year as a research assistant, focusing on NTDs and one year as a teaching assistant, focusing on Pharmacology.

Drugs 105
article thumbnail

World Malaria Day 2021

The Pharma Data

In 2020, we discovered another novel malaria therapy, INE963, which has an entirely new mechanism of action and is expected to begin clinical trials in 2021. R&D partnerships to combat drug-resistant malaria in Africa. INE963 is a fast-acting, long-lasting antimalarial that could potentially be delivered as a single-dose cure.